- Home
- CVLT vs HALO Comparison
CVLT vs HALO Comparison
Compare CVLT & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVLT
- HALO
- Stock Information
- Founded
- CVLT 1996
- HALO 1998
- Country
- CVLT United States
- HALO United States
- Employees
- CVLT N/A
- HALO N/A
- Industry
- CVLT Computer Software: Prepackaged Software
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CVLT Technology
- HALO Health Care
- Exchange
- CVLT Nasdaq
- HALO Nasdaq
- Market Cap
- CVLT 6.8B
- HALO 7.4B
- IPO Year
- CVLT 2006
- HALO N/A
- Fundamental
- Price
- CVLT $170.60
- HALO $65.87
- Analyst Decision
- CVLT Buy
- HALO Buy
- Analyst Count
- CVLT 11
- HALO 9
- Target Price
- CVLT $173.33
- HALO $63.78
- AVG Volume (30 Days)
- CVLT 473.7K
- HALO 2.0M
- Earning Date
- CVLT 04-29-2025
- HALO 05-06-2025
- Dividend Yield
- CVLT N/A
- HALO N/A
- EPS Growth
- CVLT N/A
- HALO 55.40
- EPS
- CVLT 1.68
- HALO 3.76
- Revenue
- CVLT $995,619,000.00
- HALO $1,084,306,000.00
- Revenue This Year
- CVLT $13.00
- HALO $20.06
- Revenue Next Year
- CVLT $11.11
- HALO $24.20
- P/E Ratio
- CVLT $101.55
- HALO $17.52
- Revenue Growth
- CVLT 18.63
- HALO 25.64
- 52 Week Low
- CVLT $105.76
- HALO $41.28
- 52 Week High
- CVLT $190.11
- HALO $70.51
- Technical
- Relative Strength Index (RSI)
- CVLT 57.21
- HALO 58.99
- Support Level
- CVLT $167.99
- HALO $58.38
- Resistance Level
- CVLT $178.53
- HALO $70.51
- Average True Range (ATR)
- CVLT 6.75
- HALO 2.50
- MACD
- CVLT 1.48
- HALO 0.88
- Stochastic Oscillator
- CVLT 76.91
- HALO 64.61
About CVLT Commvault Systems Inc.
CommVault Systems Inc provides data and information management software applications and services. The firm sells software licenses and services to large global enterprises, small- and midsize businesses, and government agencies through both its salesforce and its network of reseller partners. Its software solutions include Commvault Complete Backup and Recovery, HyperScale, Hedvig, and Metallic. The company operates in the United States and exports to many other countries.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.